Standard dressing regimen

OTHER2 trials

Sponsors

Organogenesis

Conditions

Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, JunctionalKeloid

Phase 1

A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids

CompletedNCT00587587

OrganogenesisKeloid

Start: 2007-12-31End: 2010-03-31Updated: 2011-08-19

Phase 3

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

TerminatedNCT00587223

OrganogenesisEpidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Junctional

Start: 2007-12-31End: 2008-12-31Updated: 2010-06-29